FDA Trending News

FDA News Update: First Xarelto Generics Approved, New Testosterone Warnings, and Stroke Treatment Approval

Mar 10, 2025

For Immediate Release:

Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:

  • On Monday, the FDA approved the first generics of Xarelto (rivaroxaban), 2.5 mg, tablets to reduce the risk of major cardiovascular events in adult patients with coronary artery disease (CAD) and to reduce the risk of major thrombotic vascular events in adult patients with peripheral artery disease (PAD), including patients who have recently undergone a lower extremity revascularization procedure due to symptomatic PAD. Anticoagulants (blood thinners) are among the most commonly prescribed medications in the U.S., and Monday’s approval of the first generics of rivaroxaban, 2.5 mg, tablets will make a direct impact on American patients who rely on anticoagulant medications. Approving safe and effective generics to help provide patients more treatment options continues to be a priority for the FDA.
  • On Friday, the FDA informed sponsors of testosterone products of new labeling changes resulting from the results of the Testosterone Replacement Therapy for Assessment of Long-term Vascular Events and Efficacy Response in Hypogonadal Men (TRAVERSE) clinical trial and the results from required postmarket ambulatory blood pressure monitoring (ABPM) studies. The labeling changes include a new warning about the risk of increased blood pressure for testosterone products that currently do not contain such labeling information.
  • On Friday, the FDA approved TNKase (tenecteplase) to treat acute ischemic stroke (AIS) in adults. The most common adverse reaction is bleeding. TNKase is for intravenous administration only and recommended dosing is available in the prescribing information. 

Related Information

Related Information

Reported by

Reviewed by

You May Also Like

Could a New Discovery Prevent Muscle Loss and Weakness as We Age?

Could a New Discovery Prevent Muscle Loss and Weakness as We Age?

,

Muscle weakness is one of the biggest challenges of aging. As people get older, they naturally lose muscle strength and muscle mass, a condition known as sarcopenia. This can make everyday activities like climbing stairs, carrying groceries, or getting up from a chair much more difficult. While exercise and good nutrition remain the best ways to slow muscle loss, researchers are searching for new treatments that target the underlying causes of age-related muscle weakness.

Could Glucosamine Supplements Worsen Alzheimer’s Disease? Here’s What Researchers Found

Could Glucosamine Supplements Worsen Alzheimer’s Disease? Here’s What Researchers Found

, ,

Many people take glucosamine supplements every day to help support their joints. It has been used for years and is one of the most popular supplements for osteoarthritis. However, a new study is raising questions about whether glucosamine could affect brain health in people with Alzheimer’s disease or mild cognitive impairment.

The Facts on Tampons and Tampon Safety

The Facts on Tampons and Tampon Safety

,

Tampons are absorbent products that you insert into your vagina to soak up menstrual flow during your period. Tampons come in different absorbency levels — like light, regular, and super — so you can pick the right one for your flow. Some have a plastic or cardboard applicator to help with insertion, and others are inserted with your finger.